Loading Complete
Tamara Lotan

Tamara Lotan, MD

Clinical and Laboratory Pathology

Highlights

Languages

  • English

Gender

Female

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Tamara Lotan

Professional Titles

  • Acting Director of Urologic Pathology, The Johns Hopkins Hospital
  • Deputy Director for Research Affairs, Department of Pathology

Primary Academic Title

Professor of Pathology

Background

Dr. Tamara Lotan is a Professor of Pathology, Oncology and Urology at the Johns Hopkins University School of Medicine. Her area of clinical expertise is urologic pathology.

Dr. Lotan received her medical degree from the University of Chicago Pritzker School of Medicine. She completed her residency in anatomic pathology at the University of Chicago Hospitals and performed a fellowship in urologic pathology at the Johns Hopkins University School of Medicine.

She is a urologic pathologist and physician-scientist whose laboratory studies tissue-based predictive and prognostic biomarkers in prostate cancer. The group has a particular interest in the molecular contributors to prostate cancer health disparities. Her group also studies mTOR signaling and its role in tumorigenesis, with a focus on renal oncogenesis.

Dr. Lotan is engaged in research training and is the co-PI of the OPTIC T32 in pathology, enabling pathology residents to engage in 2-3 years of laboratory research. She is currently the Deputy Director for Research Affairs in the Department of Pathology.

Additional Academic Titles

Joint Appointment in Urology, Professor of Oncology

Research Interests

Prostate cancer, kidney cancer

Research Summary

Dr. Tamara Lotan is a urologic pathologist who studies how oncogenic signaling pathways regulate epithelial morphogenesis during embryonic development and tumorigenesis. Using novel transgenic mouse models combined with human tumor tissue samples, Dr. Lotan is defining the roles of these critical signals in epithelial development and tumor progression.

Selected Publications

  • Salles DC, Asrani K, Woo J, Vidotto T, Liu HB, Vidal I, Matoso A, Netto GJ, Argani P, Lotan TL. GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms. J Pathol. 2022. 257(2):158-171; PMID: 35072947.
  • Asrani K, Woo J, Mendes AA, Schaffer E, Vidotto T, Villanueva CR, Feng K, Oliveira L, Murali S, Liu HB, Salles DC, Lam B, Argani P, Lotan TL.  An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss. Nat Commun. 2022;13(1):6808. PMID: 36357396.
  • Mendes AA, Lu J, Kaur HB, Zheng S, Xu J, Hicks J, Weiner AB, Schaeffer EM, Ross AE, Balk SP, Taplin M-E, Lack NA, Tekoglu E, Maynard JP, De Marzo AM, Antonarakis ES, Sfanos KS, Joshu CE, Shenderov E*, Lotan TL*. Association of B7-H3 Expression with Racial Ancestry, Immune Cell Density, and AR Activation in Prostate Cancer. Cancer. 2022; 15;128(12):2269-2280. *Equal Contribution. PMID: 35333400.
  • Vidotto T, Imada EL, Faisal F, Murali S, Mendes AA, Kaur H, Zheng S, Xu J, Schaeffer EM, Isaacs WB, Sfanos KS, Marchionni L, Lotan TL. Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer_. JCI Insight_. 2023; 8(3)e162409. PMID: 36752203.
  • Erak E, Oliveira LD, Mendes AA, Dairo O, Ertunc O, Kulac I, Baena-Del Valle JA, Jones T, Hicks JL, Glavaris S, Guner G, Vidal ID, Markowski M, de la Calle C, Trock BJ, Meena A, Joshi U, Kondragunta C, Bonthu S, Singhal N, De Marzo AM, Lotan TL. Predicting Prostate Cancer Molecular Subtype with Deep Learning on Histopathologic Images. Mod. Pathol. 2023_;_ 36(10):100247. PMID: 37307876.

Honors

  • 2022-Elected to Interurban Clinical Club

Memberships

  • College of American Pathology
  • International Society of Urologic Pathology
  • United States and Canadian Academy of Pathology

Locations

  1. The Johns Hopkins Hospital
    • 1800 Orleans Street, Baltimore, MD 21287

    Expertise

    Education

    Johns Hopkins University School of Medicine

    Fellowship, Pathology, 2008

    University of Chicago Medicine

    Residency, Anatomic Pathology, 2007

    University of Chicago Medicine

    Residency, Anatomic Pathology, 2005

    University of Chicago Pritzker School of Medicine

    Medical Education, MD, 2003

    Board Certifications

    Anatomic Pathology

    American Board of Pathology, 2007

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)